niryuu/sni-each-converted huggingface dataset:
CONCLUSION: In this case of O. sulphureo-ochraceum as a human pathogen, the organism caused endophthalmitis after cataract extraction.
Output: non-adverse drug event
The management of unresectable metastatic melanoma is a major clinical challenge because of the lack of reliably effective systemic therapies.
Output: non-adverse drug event
Post-transfusion purpura as the main manifestation of a trilineal transfusion reaction, responsive to steroids: flow-cytometric investigation of granulocyte and platelet antibodies.
Output: non-adverse drug event
RESULTS: Best corrected visual acuity before injection was 6/60 in the left eye.
Output: non-adverse drug event
Other mechanisms have been postulated by other investigators.
Output: non-adverse drug event
Most studies report incidence rates ranging from 1.5 to 3%.
Output: non-adverse drug event
Amiodarone was approved to treat recurrent ventricular fibrillation or sustained ventricular tachyarrhythmia that has been resistant to other medications since 1986.
Output: non-adverse drug event
Mr. C. was less tired and had more energy following his first and subsequent courses of therapy.
Output: non-adverse drug event
Hypersensitivity reactions involving the kidneys can occur with any of the penicillin groups.
Output: non-adverse drug event
The prevalence of TD was 3.96% (4/101).
Output: non-adverse drug event
Nonsteroidal antiinflammatory agents (NSAIDs), especially naproxen and other propionic acid derivatives, appear to be the most common offenders.
Output: non-adverse drug event
CONCLUSIONS: Physicians should be aware that drug-induced AIN can be associated with proton-pump inhibitors.
Output: non-adverse drug event
No side effects or drug interactions were observed.
Output: non-adverse drug event
Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis.
Output: non-adverse drug event
When patients are prescribed tolterodine and warfarin concurrently, clinicians should monitor INR carefully, and a reduction in warfarin dosage may be required.
Output: non-adverse drug event
A case of successful treatment of antibiotic-associated pseudomembranous colitis with oral metronidazole is reported.
Output: non-adverse drug event
He was transferred when he developed pancytopenia, fever, severe mucositis, ileus and peripheral neuropathy.
Output: non-adverse drug event
We describe a case that involves fracture of a stent deployed to nominal pressure.
Output: non-adverse drug event
Calcium antagonists are drugs commonly prescribed for the treatment of hypertension, angina pectoris, cardiac arrhythmias and other disorders because of their efficacy and tolerability.
Output: non-adverse drug event
He was afebrile, tachycardic, and tachypneic and had an oxygen saturation of 94% while breathing room air.
Output: non-adverse drug event
The clinical features and different drug-induced movement scales showed an outstanding improvement after tetrabenazine was started.
Output: non-adverse drug event
The patient may have concomitant systemic disease, and the injury occurs with relatively mild trauma.
Output: non-adverse drug event
Analyzing the cardiac time intervals during pregnancy can improve perinatal outcome.
Output: non-adverse drug event
Protein in vitamin K absence (PIVKA) is the prothrombin precursor found in plasma when carboxylation to prothrombin is impaired.
Output: non-adverse drug event
The eighth exhibited concentric constriction.
Output: non-adverse drug event
Effective management of the transplant recipient depends on preventing excessive vasoconstriction, usually with calcium channel blocking agents.
Output: non-adverse drug event
Type I, blue-black pigmentation confined to sites of scarring or inflammation on the face; Type II, blue-grey circumscribed pigmentation of normal skin of the lower legs and forearms; and Type III, diffuse muddy brown pigmentation of normal skin accentuated in sun-exposed areas.
Output: non-adverse drug event
Both asthma and thyroid disease are common disorders that occasionally occur together.
Output: non-adverse drug event
RESULTS: The patients sought treatment ten to 20 weeks (mean, 15 weeks) postoperatively.
Output: non-adverse drug event
Electroencephalography (EEG) with polygraphic recording revealed tonic status epilepticus.
Output: non-adverse drug event
A case of severe hyperlipidemia caused by long-term tube feedings.
Output: non-adverse drug event
OBJECTIVE: We report an adult case of nasopharyngeal carcinoma treated with radical chemo-radiotherapy, with subsequent development of a histologically proved temporal cavernous haemangioma within the radiation field.
Output: non-adverse drug event
Pulmonary thromboembolism (PTE) in leukemic children undergoing intensive chemotherapy should be promptly recognized so that specific therapy can be started.
Output: non-adverse drug event
The results of our investigation were inconclusive, but suggested that the endoscope could have been responsible for some of the cases.
Output: non-adverse drug event
Salmon calcitonin in the treatment of post herpetic neuralgia.
Output: non-adverse drug event
Antibodies to native or ultraviolet-irradiated DNA were not demonstrated.
Output: non-adverse drug event
Considerable improvement of myasthenic symptoms was seen in all patients within 3-6 months after the initiation of this therapy.
Output: non-adverse drug event
To date, stent fractures reported have been related to aggressive post dilation.
Output: non-adverse drug event
A 44-year-old man was admitted for disturbance of consciousness caused by progressive hydrocephalus.
Output: non-adverse drug event
The authors describe a 6-year-old boy who developed pulmonary tuberculosis during intensive chemotherapy for acute myeloblastic leukemia (AML).
Output: non-adverse drug event
A literature search conducted to determine the mechanism behind the antagonism of this overdose showed that promethazine interacts with receptors in the central nervous system.
Output: non-adverse drug event
Cytomegalovirus infection is a potentially fatal complication of treatment induced immunosuppression in patients with inflammatory bowel disease.
Output: non-adverse drug event
HDR in young children should be restricted to controlled clinical trials until long-term morbidity and efficacy results are obtained from pilot studies.
Output: non-adverse drug event
Severe systemic cytomegalovirus infections in patients with steroid-refractory ulcerative colitis treated by an oral microemulsion form of cyclosporine: report of two cases.
Output: non-adverse drug event
METHODS: We report a patient with symptoms of small bowel obstruction whose diagnosis was confirmed by previous operation owing to a well-known pathology due to an unusual reason, perforation, which was masqueraded by therapeutic drugs.
Output: non-adverse drug event
Besides hysterectomy, the treatment options for adenomyosis have been limited.
Output: non-adverse drug event
The connective tissue disease was characterized by an erythematous rash, hair loss, nephritis, splenomegaly, seizures, and coma.
Output: non-adverse drug event
Histopathologic examination and direct immunofluorescence test were consistent with IgA bullous dermatosis.
Output: non-adverse drug event
CONCLUSION: The final interpretation of the lesions was multiple focal radiation necrosis based on perfusion abnormalities after chemotherapy and conformal hyperfractionated radiotherapy, probably due to an individually enhanced vulnerability of the cerebral vessels.
Output: non-adverse drug event
A 47-year-old male patient developed sepsis and monoarticular arthritis following autologous stem cell transplantation for recurrent Hodgkin's disease.
Output: non-adverse drug event
SUMMARY: A 29-year-old woman sought treatment from a pulmonologist for a dry, hacking, constant cough not relieved by fast-acting inhalers or narcotic cough medications that had lasted for three weeks.
Output: non-adverse drug event
A bubble in the inferior sagittal sinus was observed on the day of the stroke, which then disappeared within 24 hours.
Output: non-adverse drug event
Quadriplegia due to lead-contaminated opium--case report.
Output: non-adverse drug event
Nonsteroidal anti-inflammatory agents may be an alternative to chemotherapy and radiotherapy in treating mesenteric desmoids.
Output: non-adverse drug event
Generalized and partial complex seizures, other neurological signs and symptoms, and laboratory data were improved after modification of her anticonvulsant regimen.
Output: non-adverse drug event
These data further suggest that degradation by the ubiquitin-proteosome-mediated system plays a role in the elimination of the DPD protein.
Output: non-adverse drug event
CASE SUMMARY: A 66-year-old man with a background history of breast carcinoma was admitted with pleuritic chest pain.
Output: non-adverse drug event
All seven patients were receiving INH daily for tuberculosis (TB) prophylaxis.
Output: non-adverse drug event
In this report, we demonstrate the fluoroquinolone class of antibiotics can be associated with prolonged electroconvulsive seizure duration.
Output: non-adverse drug event
Tacrolimus was substituted for cyclosporine on day 20; on day 21 amlodipine was initiated to manage hypertension.
Output: non-adverse drug event
Clinical signs included central nervous system symptoms (69%), gastrointestinal complaints (87%), visual disturbances (69%) and metabolic acidosis (94%).
Output: non-adverse drug event
Dramatic clinical improvement occurred in 2 patients treated with high dose steroids.
Output: non-adverse drug event
Recent efforts have focused on heightened surveillance to detect contamination before transfusion to limit recipient morbidity and mortality.
Output: non-adverse drug event
Diuresis returned within 12 h.
Output: non-adverse drug event
Complications in the use of prochlorperazine.
Output: non-adverse drug event
Drug-induced aseptic meningitis (DIAM) is commonly seen with nonsteroidal anti-inflammatory drugs (NSAIDS), antibiotics (with TMP/SMX being the most frequently implicated), intravenous immunoglobulins and OKT3 antibodies.
Output: non-adverse drug event
Some of these patients exhibit marked bradycardia (more than 20% deviation from the lowest age-adjusted normal values) while maintaining an arterial blood pressure within an acceptable normal range.
Output: non-adverse drug event
CASE DESCRIPTION: A 21-year-old male was initially evaluated because of a large mass that had been growing for 7 months.
Output: non-adverse drug event
The area healed slowly over 7 weeks, but there was a residual loss of cutaneous sensation.
Output: non-adverse drug event
Three eyes had a UCVA of 20/20(-2) or better and a BCVA of 20/20(-1) or better.
Output: non-adverse drug event
This case of embolism into bone due to GEE is a rare complication which indisputably establishes a link between the spontaneously septic cavity of the bowel and bone tissue by way of blood via the interstices of the fabric.
Output: non-adverse drug event
Tumor necrosis factor (TNF) alpha inhibitors are effective in the treatment of inflammatory rheumatic diseases.
Output: non-adverse drug event
The maculopapular rash progressed to formation of confluent nodules, plaques and finally erythroderma with lymphadenopathy and hepatosplenomegaly.
Output: non-adverse drug event
Computed Tomography was used to demonstrate the increased retro-orbital fat.
Output: non-adverse drug event
The response to surgical drainage and antimicrobial therapy was dramatic in both dogs, but one dog experienced a drug reaction to trimethoprim-potentiated sulfonamide.
Output: non-adverse drug event
METHODS: Switching of agents took place in two ways: converting only antipsychotic medications followed by other psychotropics, and changing all psychotropics simultaneously.
Output: non-adverse drug event
After 4 months, the pain had almost entirely disappeared.
Output: non-adverse drug event
Surgically induced necrotizing scleritis in a patient with ankylosing spondylitis.
Output: non-adverse drug event
OBJECTIVE: To describe a newly recognized adverse effect of imiquimod.
Output: non-adverse drug event
No anti-Xa activity was demonstrated in breast milk.
Output: non-adverse drug event
Her case was complicated by social and behavioral issues.
Output: non-adverse drug event
This therapeutic strategy resulted in normalization of the elevated EBV-DNA titers and disappearance of the monoclonal B cell populations.
Output: non-adverse drug event
These antiplatelet agents were continued during the perioperative period.
Output: non-adverse drug event
A complete immunohistochemical study was performed on heart specimens.
Output: non-adverse drug event
Previously reported cases of persistent proximal right umbilical vein have shown a variety of other malformations but a single umbilical artery has been the most consistent.
Output: non-adverse drug event
Arteriography demonstrated extensive pruning of the distal arterial tree along with bilateral external iliac artery dissections - a finding that is not often associated with young, normotensive patients with chronic ergot toxicity.
Output: non-adverse drug event
At delivery the umbilical cord plasma concentration was similar to that in the maternal venous plasma.
Output: non-adverse drug event
A week before the onset of hepatitis, the patient complained of upper gastrointestinal symptoms and was treated for gastritis.
Output: non-adverse drug event
The median survival was 17 months in patients who had received no prior treatment, and 5 months in those who had received prior chemotherapy.
Output: non-adverse drug event
The patient's mental status returned to baseline after treatment with intravenous phenytoin and discontinuation of ifosfamide therapy.
Output: non-adverse drug event
Cat-scratch disease, primarily caused by Bartonella henselae, typically presents with regional adenopathy, and the role of antibiotics in the treatment is debatable.
Output: non-adverse drug event
This report deals with a 54-year-old man with loss of memory.
Output: non-adverse drug event
Pathology evaluation of a specimen revealed a high-grade osteoblastic osteosarcoma.
Output: non-adverse drug event
A 39 year old white male with a 55% total body surface burn who developed neuroleptic malignant syndrome (NMS) during his acute course is reported.
Output: non-adverse drug event
A 41-year-old black female with psoriasis developed photosensitivity and a Koebner reaction while receiving phototherapy.
Output: non-adverse drug event
The aim of this phase I study was to determine the toxicity profile and the optimal dosage of KW-2149.
Output: non-adverse drug event
Therefore, these patients might have to be treated with granulocyte colony-stimulating factor to be able to recover from severe neutropenia.
Output: non-adverse drug event
Subsequent cardiac arrest and prolonged cardiogenic shock required aggressive pharmacologic support, intraaortic balloon pump insertion, and mechanical ventilation.
Output: non-adverse drug event
Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy.
Output: non-adverse drug event
The tendency to develop AV block in a patient who is euthyroid was reduced by bypass tract conduction.
Output: non-adverse drug event
Caution should be taken when designing estrogen-related experiments involving Brown Norway rats and other potentially sensitive strains.
Output: non-adverse drug event
Proposed mechanisms for phenytoin hypersensitivity include antigen-antibody reactions, alteration of lymphocyte function, and an enzyme abnormality causing the production of toxic metabolites.
Output: non-adverse drug event
Examination revealed facial erythema and eczema, ectropion, blepharitis, chemosis, lid teleangectasia, and contact lens-related corneal edema.
Output: non-adverse drug event
Changes in serotonergic function may play a more widespread role in the pathophysiology of seizure disorders than hitherto thought.
Output: non-adverse drug event
Clinical and radiological improvements were achieved after treatment with corticosteroid and tamoxifen.
Output: non-adverse drug event
A 47-year-old woman presented to our clinic 1 day after an intervention for a tibial shaft fracture because of sudden onset of chest pain and palpitations.
Output: non-adverse drug event
All seven patients who were given an oral formulation of cyclosporine tolerated it well after a reaction to the intravenous infusion.
Output: non-adverse drug event
The patient did well after the operation and returned to normal activity.
Output: non-adverse drug event
G-CSF was used as an adjunctive therapy with discontinuation of carbimazole, barrier nursing and a broad-spectrum antibiotic regimen to treat her neutropenic sepsis.
Output: non-adverse drug event
Power spectrum analysis of heart rate variability demonstrated marked abnormalities in autonomic nervous system activity.
Output: non-adverse drug event
The recombinant human IgG1 monoclonal antibody specific for human TNF-a adalimumab (Humira) has been recently introduced for the treatment of moderate/severe psoriasis.
Output: non-adverse drug event
Pyomyositis was completely resolved following the surgical drainage and the antistaphylococcal antibiotic treatment.
Output: non-adverse drug event
These patients were treated by the continuous administration of an estrogen-progestogen combination for 6 months.
Output: non-adverse drug event
None of the patients had experienced visual hallucinations before this event.
Output: non-adverse drug event
This is particularly the case for children, who often exhibit resistance to intramuscular or rectal administration of drugs.
Output: non-adverse drug event
Studies in the father suggest that the aldosterone production by his adrenals is hyperresponsive to adrenocorticotropic hormone (ACTH).
Output: non-adverse drug event
OBJECTIVE: To raise awareness of a rare but serious adverse effect of a commonly used medication.
Output: non-adverse drug event
Removal of the deposit ended the corneal erosion and returned visual acuity to normal.
Output: non-adverse drug event
A MEDLINE search from 1966 to December 2000 revealed no reports of toxic epidermal necrolysis, erythema multiforme, or Stevens-Johnson syndrome due to ofloxacin therapy.
Output: non-adverse drug event
Infliximab therapy in pediatric Crohn's pouchitis.
Output: non-adverse drug event
Sunitinib is an orally administered multitargeted tyrosine kinase inhibitor that has demonstrated substantial antitumour activity in patients with metastatic renal cell carcinoma.
Output: non-adverse drug event
However, the toxicity profile of leflunomide in patients with underlying GVHD remains to be defined.
Output: non-adverse drug event
We also discuss the apparent increased thrombotic risk in patients receiving a VAD for chemotherapy induced cardiomyopathy and the implications this may have for the choice of VAD.
Output: non-adverse drug event
Uncertainty in medical decision making techniques occurs in the specification of both decision tree probabilities and utilities.
Output: non-adverse drug event
In more than half of the cases there was evidence of prolonged elimination t1/2 or rebound of a serum concentration during the elimination phase corresponding to either an additional compartment or enterohepatic circulation of 6MP.
Output: non-adverse drug event
Laryngeal necrosis after combined chemotherapy and radiation therapy.
Output: non-adverse drug event
We report a case of acute popliteal artery occlusion after arthroscopic posterior cruciate ligament reconstruction.
Output: non-adverse drug event
In the second block of the consolidation phase, 10 hours after triple intrathecal treatment, we realized that instead of 12 mg, 120 mg of methotrexate had accidentally been given.
Output: non-adverse drug event
Semiquantitative measurements of cytokine mRNA in his bronchoalveolar lavage cells prior to therapy with IFN-alpha revealed high levels of IL-4 and IL-10 mRNA, which decreased significantly with treatment.
Output: non-adverse drug event
Air conditioning and proper ventilation of the operating room, the use of coolant sprays, good suction and proper handling of amalgam waste is recommended.
Output: non-adverse drug event
Few have been described after liver transplantation.
Output: non-adverse drug event
The tyrosine kinase activity and its effects represent a potential pharmacologic target of tyrosine kinase inhibitors, such as imatinib.
Output: non-adverse drug event
Trazodone therapy was continued or reinstated shortly after the hypomanic episode without further evidence of hypomania.
Output: non-adverse drug event
Her course, history and outcome are presented and the pharmacokinetics, the mechanism of action, signs and symptoms and treatment of strychnine poisoning are reviewed.
Output: non-adverse drug event
Late repeat restenosis was treated with a third (Taxus, Boston Scientific, Maple Grove, Minnesota, USA) stent that was deployed through the previously implanted stent struts.
Output: non-adverse drug event
This idea should be revised because functional imaging showed that this RLS patient had no dopamine depletion.
Output: non-adverse drug event
In this report, we suppose the possibility to develop a foetal malformations after a long-term wash out from isotretinoin therapy.
Output: non-adverse drug event